| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.29 | 0.3 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.22 | 5e-05 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.18 | 0.6 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.2 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.03 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.5 |